Edwards Lifesciences Corp
NYSE:EW
| Market Cap (Intraday) | 53.14B |
| Current PE | 37.69 |
| Forward PE | 32.18 |
| 2yr Forward PE | 28.66 |
| 10-Day MA | $87.70 |
| 50-Day MA | $89.90 |
| 200-Day MA | $78.47 |
Edwards Lifesciences Corp Stock, NYSE:EW
1 Edwards Way, Irvine, California 92614
United States of America
Phone: +1.949.250.2500
Number of Employees: 19800
Description
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.